Catalyst Wire Dossier Catalyst Wire Dossier

5-Fluoro-2'-Deoxcytidine

5-fluorodeoxycytidine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5-Fluoro-2'-Deoxcytidine, covering 2015-05-06 to 2015-05-06. Get the full timeline:

Most recent: Clinical Trial Update: 5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer [Phase 1]

See pricing